ARTG 388831Bone matrix implant, synthetic
ARTG ID: 388831 · Baxter Healthcare Pty Ltd · Apatech Limited · Class I · Started May 23, 2022
Good Name: Baxter Healthcare Pty Ltd - Bone matrix implant, synthetic
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General-Export
- ARTG ID
- 388831
- Start Date
- May 23, 2022
- Effective Date
- May 23, 2022
- Name
- Apatech Limited
- Country
- United Kingdom
- Address
- 360 Centennial Avenue Centennial Park, Elstree, Hertfordshire, WD6 3TJ
Inductigraft is a bone graft substitute, indicated to be used in place of corticocancellous, or cancellous allograft or autograft bone in mechanical environments which experience either low load requirements or compression. Surgical applications for the Inductigraft bone graft substitute are: - Spinal fusion, e.g., posterolateral spinal and interbody fusions, where appropriate hardware such as pedicle screws or an interbody cage device is used to relieve the graft site from physiological loads, - Small void filling, e.g., following bone fracture reduction.
Access comprehensive regulatory information for Bone matrix implant, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is registered under ARTG number 388831 and sponsored by Baxter Healthcare Pty Ltd, manufactured by Apatech Limited in United Kingdom. The device registration started on May 23, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.